Literature DB >> 8423046

Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress.

D C Marsh1, P K Vreugdenhil, V E Mack, F O Belzer, J H Southard.   

Abstract

Isolated hepatocytes, suspended in an organ preservation solution, can be preserved at 4 degrees C for up to 6 days. After preservation, normothermic-normoxic incubation causes loss of hepatocyte viability. The addition of 3 mmol/L glycine to the rewarming medium prevents the loss of viability. In this study we investigated the cytoprotective effects of glycine under many conditions known to cause hepatocellular injury to understand the mechanism of cold-induced injury in the liver. Hepatocytes were suspended in modified Krebs-Henseleit buffer with or without 3 mmol/L glycine and exposed to agents or conditions known to induce cell death. Hepatocyte viability was assessed by measuring the percentage of lactate dehydrogenase leakage from the cells and the concentration of ATP during incubation at 37 degrees C under room air for up to 90 min. Mitochondrial inhibitors (potassium cyanide and carbonyl cyanide m-chlorophenylhydrazone); calcium ionophores (ionomycin and A23187); an oxidizing agent, tert-butyl hydroperoxide; and anoxia were all used to cause cell injury. Hepatocytes were also isolated from fasted rats and hypothermically preserved as another model of cell death. Other amino acids were also tested in the hypothermic preservation model to study the specificity of the amino acid requirement for prevention of lactate dehydrogenase leakage. Of the amino acids tested, only alanine (10 mmol/L) and the combination of alanine (3 mmol/L) and serine (3 mmol/L) were as effective as glycine in preventing lactate dehydrogenase release in the hypothermic preservation model.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423046

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  The role of glycine in regulated cell death.

Authors:  Joel M Weinberg; Anja Bienholz; M A Venkatachalam
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

Review 2.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Molecular perturbations restrict potential for liver repopulation of hepatocytes isolated from non-heart-beating donor rats.

Authors:  Yuta Enami; Brigid Joseph; Sriram Bandi; Juan Lin; Sanjeev Gupta
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

4.  Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage.

Authors:  Alison Howard; Imran Tahir; Sajid Javed; Sarah M Waring; Dianne Ford; Barry H Hirst
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

5.  Dietary glycine blunts liver injury after bile duct ligation in rats.

Authors:  Matthias Froh; Zhi Zhong; Peter Walbrun; Mark Lehnert; Susanne Netter; Reiner Wiest; Lars Conzelmann; Erwin Gabele; Claus Hellerbrand; Jurgen Scholmerich; Ronald-G Thurman
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

6.  Inhibition of warm ischemic injury to rat liver, pancreas, and heart grafts by controlling the nutritional status of both donor and recipient.

Authors:  V Nishihara; R Sumimoto; Y Fukuda; J H Southard; T Asahara; K Dohi
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

7.  Plasma metabolomic profiling of dairy cows affected with ketosis using gas chromatography/mass spectrometry.

Authors:  Hongyou Zhang; Ling Wu; Chuang Xu; Cheng Xia; Lingwei Sun; Shi Shu
Journal:  BMC Vet Res       Date:  2013-09-26       Impact factor: 2.741

8.  Glycine and glycine receptor signalling in non-neuronal cells.

Authors:  Jimmy Van den Eynden; Sheen Saheb Ali; Nikki Horwood; Sofie Carmans; Bert Brône; Niels Hellings; Paul Steels; Robert J Harvey; Jean-Michel Rigo
Journal:  Front Mol Neurosci       Date:  2009-08-20       Impact factor: 5.639

9.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

10.  Mitochondrial Impairment as a Key Factor for the Lack of Attachment after Cold Storage of Hepatocyte Suspensions.

Authors:  Gesine Pless-Petig; Björn Walter; Anja Bienholz; Ursula Rauen
Journal:  Cell Transplant       Date:  2017-12       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.